Research by Isabelle Gagnon-Arpin

(Displaying 1 to 20 of 23) | Page: 1 2 | Next »
L’approvisionnement fondé sur la valeur (AFV) est une approche avancée en matière d’achats qui répond à l’épineux problème de savoir comment améliorer les soins...
The Conference Board of Canada | 27 pages | December 2022 | by Isabelle Gagnon-Arpin, Nicholas Moroz, Chad Leaver
In this final instalment of our three-part value-based procurement (VBP) research series, we propose a strategy and recommendations for scaling VBP as a component of value-based...
The Conference Board of Canada | 23 pages | December 2022 | by Isabelle Gagnon-Arpin, Chad Leaver, Isabella Moroz
Dans ce troisième et dernier volet de notre série de travaux de recherche sur l’approvisionnement fondé sur la valeur (AFV), nous proposons une stratégie et des recommandations...
The Conference Board of Canada | 25 pages | December 2022 | by Isabelle Gagnon-Arpin, Chad Leaver, Isabella Moroz
Value-based procurement (VBP) is an advanced approach to purchasing that addresses the challenging problem of how to improve patient care and outcomes while containing healthcare...
The Conference Board of Canada | 27 pages | October 2022 | by Isabelle Gagnon-Arpin, Chad Leaver, Isabella Moroz, Nicholas Moroz
Cette mise à jour du rapport de 2017 du Conference Board du Canada intitulé Understanding the Gap, analyse la disponibilité des couvertures pour les médicaments sur ordonnance...
Le Conference Board du Canada | 23 pages | August 2022 | by Isabelle Gagnon-Arpin, Wanlin Chen, Chad Leaver
Value-based procurement (VBP) is an advanced approach to purchasing that addresses the challenging problem of how to improve patient care and outcomes while containing healthcare...
The Conference Board of Canada | 14 pages | August 2022 | by Isabelle Gagnon-Arpin, Isabella Moroz, Nicholas Moroz, Chad Leaver
L’approvisionnement fondé sur la valeur (AFV) est une approche avancée en matière d’achat qui répond au défi épineux d'améliorer les soins et les résultats pour les...
Le Conference Board du Canada | 15 pages | August 2022 | by Isabelle Gagnon-Arpin, Chad Leaver, Isabella Moroz, Nicholas Moroz
This data briefing, an update to The Conference Board of Canada’s 2017 Understanding the Gap, analyzes the availability of prescription drug coverage across the country and the...
The Conference Board of Canada | 22 pages | July 2022 | by Isabelle Gagnon-Arpin, Wanlin Chen, Chad Leaver
Cette publication en ligne porte sur l’assurance-médicaments d'ordonnance au Canada et sur l’écart entre les personnes couvertes et les personnes non couvertes.
The Conference Board of Canada | Website | May 2022 | by Isabelle Gagnon-Arpin
This online experience looks at prescription drug insurance in Canada and the gap between the insured and the uninsured.
The Conference Board of Canada | Website | May 2022 | by Isabelle Gagnon-Arpin
In this issue briefing, the authors model the economic burden of cardiovascular disease in Colombia—the direct costs of delivering health care services and the indirect costs from...
The Conference Board of Canada | 20 pages | January 2021 | by Junyi Feng, Isabelle Gagnon-Arpin
In this issue briefing, the authors discuss how different strategies are needed to counter the burden of cardiovascular disease in Saudi Arabia. Large-scale public health interventions...
The Conference Board of Canada | 20 pages | January 2021 | by Isabelle Gagnon-Arpin, Junyi Feng
In this issue briefing, the authors model the economic burden of cardiovascular disease in Mexico—the direct costs of delivering health care services and the indirect costs from...
The Conference Board of Canada | 19 pages | January 2021 | by Junyi Feng, Isabelle Gagnon-Arpin
In this issue briefing, the authors model the economic burden of cardiovascular disease in the United Arab Emirates—the direct costs of delivering health care services and the...
The Conference Board of Canada | 18 pages | January 2021 | by Junyi Feng, Isabelle Gagnon-Arpin
In this issue briefing, the authors discuss how different strategies are needed to counter the burden of cardiovascular disease in Saudi Arabia. Large-scale public health interventions...
The Conference Board of Canada | 19 pages | January 2021 | by Junyi Feng, Isabelle Gagnon-Arpin
In this issue briefing, the authors discuss how different strategies are needed to counter the burden of cardiovascular disease in Mexico. Large-scale public health interventions...
The Conference Board of Canada | 19 pages | January 2021 | by Junyi Feng, Isabelle Gagnon-Arpin
In this issue briefing, the authors discuss how different strategies are needed to counter the burden of cardiovascular disease in Colombia. Large-scale public health interventions...
The Conference Board of Canada | 19 pages | January 2021 | by Junyi Feng, Isabelle Gagnon-Arpin
In this issue briefing, the authors discuss how different strategies are needed to counter the burden of cardiovascular disease in the United Arab Emirates. Large-scale public...
The Conference Board of Canada | 18 pages | January 2021 | by Junyi Feng, Isabelle Gagnon-Arpin
This report examines cancer mortality rates in Canada, with a focus on lung, colorectal, and prostate cancers, and compares our national and provincial rates against those of 16...
The Conference Board of Canada | 30 pages | December 2020 | by Junyi Feng, Isabelle Gagnon-Arpin, Monika Slovinec D’Angelo
Les immunomodulateurs ralentissent les lésions au cerveau et diminuent la fréquence des poussées chez les patients atteints de la sclérose en plaques. Alors, pourquoi les Canadiens...
Le Conference Board du Canada | 53 pages | December 2020 | by Junyi Feng, Isabelle Gagnon-Arpin, Nicholas Moroz, Monika Slovinec D’Angelo
(Displaying 1 to 20 of 23) | Page: 1 2 | Next »